Ranbaxy goes to court to challenge transfer pricing ruling
Ranbaxy Laboratories, an Indian pharmaceuticals company, has said that it will challenge a transfer pricing ruling by the country's Income Tax Appellate Tribunal (ITAT) in the high court
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
